Buspirone

Revision as of 16:25, 27 September 2011 by Matt Pijoan (talk | contribs) (Protected "Buspirone": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Synonyms / Brand Names: Ansial, Ansiced, Anxiron, Axoren, Bespar , Buspar, Buspimen, Buspinol, Buspisal, Censpar, Lucelan, Narol, Travin, Wellbutrin XL

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Dosing and Administration

The recommended initial dose is 15 mg daily (7.5 mg b.i.d.). To achieve an optimal therapeutic response, at intervals of 2 to 3 days the dosage may be increased 5 mg per day, as needed. The maximum daily dosage should not exceed 60 mg per day. In clinical trials allowing dose titration, divided doses of 20 mg to 30 mg per day were commonly employed.

The bioavailability of buspirone is increased when given with food as compared to the fasted state. Consequently, patients should take buspirone in a consistent manner with regard to the timing of dosing; either always with or always without food.



FDA Package Insert Resources
Indications, Contraindications, Side Effects, Drug Interactions, etc.

Calculate Creatine Clearance
On line calculator of your patients Cr Cl by a variety of formulas.

Convert pounds to Kilograms
On line calculator of your patients weight in pounds to Kg for dosing estimates.

Publication Resources
Recent articles, WikiDoc State of the Art Review, Textbook Information

Trial Resources
Ongoing Trials, Trial Results

Guidelines & Evidence Based Medicine Resources
US National Guidelines, Cochrane Collaboration, etc.

Media Resources
Slides, Video, Images, MP3, Podcasts, etc.

Patient Resources
Discussion Groups, Handouts, Blogs, News, etc.

International Resources
en Español






FDA Package Insert Resources

Indications

Contraindications

Side Effects

Drug Interactions

Precautions

Overdose

How Supplied

Pharmacokinetics and Molecular Data

FDA label

FDA on Buspirone

Return to top

Publication Resources

Most Recent Articles on Buspirone

Review Articles on Buspirone

Articles on Buspirone in N Eng J Med, Lancet, BMJ

WikiDoc State of the Art Review

Textbook Information on Buspirone

Return to top

Trial Resources

Ongoing Trials with Buspirone at Clinical Trials.gov

Trial Results with Buspirone

Return to top

Guidelines & Evidence Based Medicine Resources

US National Guidelines Clearinghouse on Buspirone

Cochrane Collaboration on Buspirone

Cost Effectiveness of Buspirone

Return to top

Media Resources

Powerpoint Slides on Buspirone

Images of Buspirone

Podcasts & MP3s on Buspirone

Videos on Buspirone

Return to top

Patient Resources

Patient Information from National Library of Medicine

Patient Resources on Buspirone

Discussion Groups on Buspirone

Patient Handouts on Buspirone

Blogs on Buspirone

Buspirone in the News

Buspirone in the Marketplace

Return to top

International Resources

Buspirone en Español

Return to top


Adapted from the FDA Package Insert.